Kathy Y. Yi
2017
In 2017, Kathy Y. Yi earned a total compensation of $994K as Senior Vice President and Chief Financial Officer at Sangamo Biosciences.
Compensation breakdown
| Non-Equity Incentive Plan | $120,377 |
|---|---|
| Option Awards | $574,560 |
| Salary | $294,358 |
| Other | $4,710 |
| Total | $994,005 |
Yi received $574.6K in option awards, accounting for 58% of the total pay in 2017.
Yi also received $120.4K in non-equity incentive plan, $294.4K in salary and $4.7K in other compensation.
Rankings
In 2017, Kathy Y. Yi's compensation ranked 9,004th out of 14,666 executives tracked by ExecPay. In other words, Yi earned more than 38.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,004 out of 14,666 | 39th |
Division Manufacturing | 3,442 out of 5,770 | 40th |
Major group Chemicals And Allied Products | 1,176 out of 2,074 | 43rd |
Industry group Drugs | 940 out of 1,730 | 46th |
Industry Biological Products, Except Diagnostic Substances | 169 out of 316 | 47th |
Source: SEC filing on April 24, 2018.
Yi's colleagues
We found four more compensation records of executives who worked with Kathy Y. Yi at Sangamo Biosciences in 2017.